Your chance to get on the next “60-Second Trade”

Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!

Jay Flatley Biography and Net Worth

CEO of Zymergen

Jay served as CEO of Illumina, a cutting-edge company in the human health space, for 17 years, and as its Executive Chair, and later Chairman of the Board, until 2021. During his tenure as CEO Jay took Illumina from $1.3 million in sales in 2000 to $2.2 billion in 2015.

In addition to being Chairman and Acting CEO of Zymergen, Jay serves as a member of the Boards of Denali Therapeutics Inc. and Coherent Inc., is an advisory board member for U.C. San Diego’s Moore Cancer Center and serves on the Board of Trustees for The Salk Institute for Biological Studies. Mr. Flatley holds a BSc and MSc (Hons) from Stanford University, along with a BA from Claremont McKenna College.

What is Jay T. Flatley's net worth?: The estimated net worth of Jay T. Flatley is at least $225,056.88 as of May 26th, 2022. Mr. Flatley owns 92,616 shares of Zymergen stock worth more than $225,057 as of December 27th. This net worth evaluation does not reflect any other investments that Mr. Flatley may own. Learn More about Jay T. Flatley's net worth.
How do I contact Jay T. Flatley?: The corporate mailing address for Mr. Flatley and other Zymergen executives is , , . Zymergen can also be reached via phone at 415-801-8073 and via email at [email protected]. Learn More on Jay T. Flatley's contact information.
Has Jay T. Flatley been buying or selling shares of Zymergen?: Jay T. Flatley has not been actively trading shares of Zymergen during the last ninety days. Most recently, on Wednesday, November 17th, Jay T. Flatley bought 100,000 shares of Zymergen stock. The stock was acquired at an average cost of $10.00 per share, with a total value of $1,000,000.00. Learn More on Jay T. Flatley's trading history.
Who are Zymergen's active insiders?: Zymergen's insider roster includes Jay Flatley (CEO), Aaron Kimball (CTO), and Zachariah Serber (Insider). Learn More on Zymergen's active insiders.

Jay T. Flatley Insider Trading History at Zymergen

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/17/2021	Buy	100,000	$10.00	$1,000,000.00

Jay T. Flatley Buying and Selling Activity at Zymergen

Zymergen Company Overview

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.

Today's Range

Now: $2.43

$2.43

50 Day Range

MA: $2.52

$2.35

$3.14

2 Week Range

Now: $2.43

$1.10

$12.42

Volume

85 shs

Average Volume

1,229,575 shs

Market Capitalization

$253.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69